These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14511503)

  • 21. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC; Kapral D; Busman TA; Paris MM
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinico-pharmacologic aspects of the use of ofloxacin].
    Kukes VG; Belitskaia RA; Dubova MN; Krasavina MIu; Posrednikova TA
    Antibiot Khimioter; 1996; 41(9):39-42. PubMed ID: 9005783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levofloxacin revisited.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):55. PubMed ID: 21738109
    [No Abstract]   [Full Text] [Related]  

  • 26. [The safety profile and tolerance of levofloxacin].
    Honorato J; Caballero E; Campanero MA; Escolar M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():44-6. PubMed ID: 10563111
    [No Abstract]   [Full Text] [Related]  

  • 27. [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community].
    Bolkovshtein M; Lederman N; Berkovitch M
    Harefuah; 2001 Nov; 140(11):1054-7. PubMed ID: 11759381
    [No Abstract]   [Full Text] [Related]  

  • 28. Levaquin induced acute tubulointerstitial nephritis--two case reports.
    Wood ML; Schlessinger S
    J Miss State Med Assoc; 2002 Apr; 43(4):116-7. PubMed ID: 11989200
    [No Abstract]   [Full Text] [Related]  

  • 29. [Musculoskeletal clinical adverse effects of ofloxacin].
    Martín Marco A; Falquera Sacrest M; Rubio Cabàllero M
    Med Clin (Barc); 1999 Nov; 113(16):635-6. PubMed ID: 10609260
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suspected role of ofloxacin in a case of arthalgia, myalgia, and multiple tendinopathy.
    Schwald N; Debray-Meignan S
    Rev Rhum Engl Ed; 1999; 66(7-9):419-21. PubMed ID: 10526383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects of levofloxacin.
    Prescrire Int; 2002 Aug; 11(60):116-7. PubMed ID: 12199267
    [No Abstract]   [Full Text] [Related]  

  • 35. Updated French guidelines for diagnosis and management of pelvic inflammatory disease.
    Brun JL; Graesslin O; Fauconnier A; Verdon R; Agostini A; Bourret A; Derniaux E; Garbin O; Huchon C; Lamy C; Quentin R; Judlin P;
    Int J Gynaecol Obstet; 2016 Aug; 134(2):121-5. PubMed ID: 27170602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of ofloxacin in acute exacerbations of chronic respiratory disease.
    Watanabe K; Yoshida M; Ishibashi T; Yamada H; Kido M; Hirose T; Maeda F; Matsuzaki Y
    Drugs; 1995; 49 Suppl 2():448-50. PubMed ID: 8549396
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
    De Wilde R
    J Chemother; 1989 Jul; 1(4 Suppl):896-7. PubMed ID: 16312693
    [No Abstract]   [Full Text] [Related]  

  • 38. [A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
    Saenko VF; Viktorov AP; Golopykho LI; Nichitaĭlo ME; Gorshevikova EV
    Klin Khir; 1995; (9-10):18-9. PubMed ID: 8697205
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis.
    Halstensen A; Voltersvik P; Gossius G; Digranes A; Peterson LE; Rolstad T; Solberg CO
    Drugs; 1995; 49 Suppl 2():454-6. PubMed ID: 8549398
    [No Abstract]   [Full Text] [Related]  

  • 40. Once-daily ofloxacin for hospitalised patients with severe bacterial infections.
    Landau Z; Arcavi L; Resnitzky P
    Drugs; 1995; 49 Suppl 2():472-3. PubMed ID: 8549404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.